These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8214054)

  • 41. Secretion of N-terminal fragment of gamma-human atrial natriuretic polypeptide.
    Itoh H; Nakao K; Mukoyama M; Sugawara A; Saito Y; Morii N; Yamada T; Shiono S; Arai H; Imura H
    Hypertension; 1988 Feb; 11(2 Pt 2):I52-6. PubMed ID: 2964404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity of serine proteases for cleavage sites on proatrial natriuretic factor.
    Fischman AJ; Wildey GM; Matsueda GR; Margolies MN; Zisfein JB; Homcy CJ; Graham RM
    Peptides; 1988; 9(6):1275-83. PubMed ID: 2977643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atrial natriuretic factor prohormone peptides are present in a variety of tissues.
    Vesely DL; Palmer PA; Giordano AT
    Peptides; 1992; 13(1):165-70. PubMed ID: 1535706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro secretion of atrial natriuretic factor: receptor-mediated release of prohormone.
    Veress AT; Milojevic S; Yip C; Flynn TG; Sonnenberg H
    Am J Physiol; 1988 May; 254(5 Pt 2):R809-14. PubMed ID: 2834970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression, purification, and in vivo activity of atrial natriuretic factor prohormone produced in Escherichia coli.
    Gierse JK; Olins PO; Devine CS; Marlay JD; Obukowicz MG; Mortensen LH; McMahon EG; Blaine EH; Seetharam R
    Arch Biochem Biophys; 1989 Jun; 271(2):441-6. PubMed ID: 2525000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification of a specific peptidase in bovine atria for the processing of pro-atrial natriuretic factor.
    Imada T; Takayanagi R; Inagami T
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():113-20. PubMed ID: 2974289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atrial natriuretic factor in human blood.
    Yamaji T; Ishibashi M; Takaku F
    J Clin Invest; 1985 Oct; 76(4):1705-9. PubMed ID: 2932472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peptides derived from atrial natriuretic polypeptide precursor in human and monkey brains.
    Itoh H; Nakao K; Mukoyama M; Hosada K; Shiono S; Morii N; Yamada T; Sugawara A; Saito Y; Arai H
    J Hypertens Suppl; 1988 Dec; 6(4):S309-13. PubMed ID: 2977167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum N-terminal proatrial natriuretic factor in children with congenital heart disease.
    Holmström H; Thaulow E; Stokke O; Lindberg H; Hall C
    Eur Heart J; 1996 Nov; 17(11):1737-46. PubMed ID: 8922924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aprotinin blocks the binding of pro atrial natriuretic peptides 1 to 30, 31 to 67, and 99 to 126 to human placental membranes.
    Vesely DL
    Am J Obstet Gynecol; 1991 Sep; 165(3):567-73. PubMed ID: 1716418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A two-site immunoradiometric assay of proatrial natriuretic factor. Application to tissue extracts.
    Thibault G; Milne R; Cantin M
    Peptides; 1988; 9(5):1059-65. PubMed ID: 2977434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoreactive prohormone atrial natriuretic peptides 1-30 and 31-67; existence of a single circulating amino-terminal peptide.
    Chen YM; Whitson PA; Cintrón NM
    Biochem Biophys Res Commun; 1990 Jan; 166(2):794-800. PubMed ID: 2137341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial natriuretic factor: a possible new gastrointestinal regulatory peptide.
    Godellas CV; Gower WR; Fabri PJ; Knierim TH; Giordano AT; Vesely DL
    Surgery; 1991 Dec; 110(6):1022-7. PubMed ID: 1836070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conversion factors of high- to low-molecular-weight forms of atrial natriuretic factor.
    Trippodo NC; Januszewicz A; Cole FE; MacPhee AA; Pegram BL; Kardon MB
    Fed Proc; 1986 Jun; 45(7):2091-5. PubMed ID: 2940118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
    Mimeault M; Fournier A; Féthiere J; De Léan A
    Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum-mediated enhancement of ANF accumulation in the culture medium of cardiac atriocytes.
    Sylvestre DL; Zisfein JB; Graham RM; Homcy CJ
    Biochem Biophys Res Commun; 1986 Oct; 140(1):151-9. PubMed ID: 2946293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Congestive heart failure: increased cardiac and extracardiac atrial natriuretic peptide gene expression.
    Poulos JE; Gower WR; Sullebarger JT; Fontanet HL; Vesely DL
    Cardiovasc Res; 1996 Nov; 32(5):909-19. PubMed ID: 8944822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
    Marleau S; Nguyen TT; Du Souich P; Bellemare M; De Lean A; Ong H
    Drug Metab Dispos; 1991; 19(1):194-9. PubMed ID: 1673398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrial natriuretic peptide increases urodilatin in the circulation.
    Vesely DL; Overton RM; Blankenship M; McCormick MT; Schocken DD
    Am J Nephrol; 1998; 18(3):204-13. PubMed ID: 9627036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.